CHTR vs SGMO · P/E 11, rev $55.09B vs rev $57.8M
Charter Communications Inc (CHTR) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the CHTR and SGMO stock pages for the full models.
Not investment advice.